Search results
Best Medicare Part D Prescription Drug Plans in 2024 - NerdWallet
Nerdwallet· 5 days agoThese Medicare Part D plans stand out for member satisfaction and low premiums.
Medicare Advantage Plans To Be Squeezed Next Year, Reduce Benefits
Forbes· 23 hours agoMedicare Advantage plans are popular. There could be significant modifications to existing Advantage...
What’s happening this week around Thurston County
The Olympian via Yahoo News· 8 hours agoThe annual Pet Parade, happening at 10:30 a.m. Saturday, will bepart of the fun, which will include live music, children’s activities by Hands on...
Here are four reasons Medicare drug-price 'negotiation' in NJ isn't truly a negotiation.
App.com | Asbury Park Press via Yahoo News· 5 days agoFor 2024, New Jersey seniors had access to about 20 standalone Medicare Part D prescription drug...
$2,000 Cap On Out-Of-Pocket Drug Costs To Help Millions Of Medicare Beneficiaries
Forbes· 5 days agoThe Inflation Reduction Act’s cap of $2,000 on annual out-of-pocket spending on outpatient drugs...
Gateway - Quartz
Quartz· 8 hours agoAfter dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug maker, develops ...
Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say
San Jose Mercury News· 3 days agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients,...
Fact check: Trump falsely claims Biden didn’t lower Americans’ insulin costs | CNN Politics
CNN.com· 3 days agoPresident Joe Biden is campaigning on his success in getting seniors with diabetes a $35-per-month...
Bear of the Day: CVS Health (CVS)
Zacks via Yahoo Finance· 20 hours agoDrugstore giant CVS faces numerous bearish headwinds, which are industry and company-specific. Investors should avoid shares over the next 6-12 months.
Weight Loss Drugs and Medicare: What You Need to Know
TheStreet.com· 4 days agoMore weight loss drugs have been approved for coverage by Medicare, but what are the challenges potential users face? Medicare has recently approved coverage of GLP-1 drugs such as Wegovy to address hypertension.
